Key facts
- This page summarizes Cigall Kadoch's Form 4 filing for Foghorn Therapeutics Inc. (FHTX).
- 0 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 02 Sep 2022, 08:07.
Cigall Kadoch - 31 Aug 2022 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)
- Reporting relationship
- Director
- Issuer ticker
- FHTX
- Reported as of
- 31 Aug 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Sep 2022, 08:07:29 UTC
- Prior SEC filing
- 22 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s /Allan Reine, M.D., Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Cigall Kadoch filed Form 4 for Foghorn Therapeutics Inc. (FHTX) on 02 Sep 2022.
Change
- Previous filing in this sequence was filed on 22 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
FHTX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 295,000
- Date
- 31 Aug 2022
- Ownership
- Direct
FHTX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,329,379
- Date
- 31 Aug 2022
- Ownership
- See Footnote
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
FHTX
holding
Derivative
Stock Options (Right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 16,000
- Date
- 31 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 16,000
- Exercise price
- $13.81
FHTX
holding
Derivative
Stock Options (Right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 12,530
- Date
- 31 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,530
- Exercise price
- $9.40
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Cigall Kadoch is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 1 footnote
Footnote F1
Shares held by the Cigall Kadoch Revocable Trust of 2021, of which the Reporting Person is the sole trustee and sole current beneficiary.